Protalix stock news
WebbGet the latest market news for Protalix Biotherapeutics (PLX). Research PLX stock and other companies. 100% free, no signups. Popular Screeners Screens. Biggest Companies Most Profitable Best Performing Worst Performing 52-Week Highs 52-Week Lows Biggest Daily Gainers Biggest Daily Losers Most Active Today Best Growth Stocks. Webb21 dec. 2024 · The Company's Common Stock will continue to trade on the NYSE American. CARMIEL, Israel, Dec. 21, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins …
Protalix stock news
Did you know?
WebbStock analysis for Protalix BioTherapeutics Inc (PLX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Webb11 apr. 2024 · Shares of Yes Bank have corrected over 39 per cent from its 52-week low of Rs 24.75, hit on December 14, 2024. The stock was in focus after the private lender announced its operational performance ...
WebbProtalix BioTherapeutics News: ... Protalix stock rises on on FDA refiling for Fabry disease drug PRX–102. Seeking Alpha 141d. Protalix BioTherapeutics GAAP EPS of -$0.07, ... Webb24 feb. 2024 · Protalix BioTherapeutics Inc. (AMEX:PLX) price on Thursday, February 23, rose 3.03% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.70. A look at the stock’s price movement, the close in the last trading session was $1.65, moving within a range a
Webb12 juli 2024 · Protalix BioTherapeutics (NYSE:PLX) has a market capitalization of $126.75 million and generates $47.64 million in revenue … Webb24 feb. 2024 · Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved by the FDA in May 2012 and, subsequently, by the regulatory authorities of other countries. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains …
Webb18 okt. 2024 · Protalix was the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner.
Webb9 aug. 2024 · Approximately principal amount $3.6 million of the 4.50% convertible notes due February 2024 have been converted into approximately 4.2 million shares of common stock since the issuance of the notes. med pharma logoWebbPLX: Protalix BioTherapeutics Inc Stock Price Quote - Tel Aviv - Bloomberg Bloomberg TV+ Bloomberg Markets The Close Romaine Bostick breaks down the day's top stories and trading action leading... medpharma ignitionWebb12 apr. 2024 · 52-week price history of PLX Stock. Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Protalix BioTherapeutics Inc.’s current trading price is 6.28% away from its 52-week high, while its distance from the 52-week low is 154.10%. naked curry noodles